NEW YORK (GenomeWeb) – Bio-Techne has licensed rights to a protein synthesis technology developed by the Medical Research Council Laboratory of Molecular Biology.

MRC Technology, the tech transfer organization for the UK's MRC, said that it has licensed to Bio-Techne the Genetically encoded Orthogonal Protection and Activated Ligation (GOPAL) technology, which enables the site-specific isopeptide bonds between proteins. The license enables the Minneapolis, Minn.-based life science research tools firm to develop reagent products using GOPAL.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.